Pediatric MS patients with a primary progressive-like disease may still have relevant inflammatory activity and may benefit from regular MS treatment

Arlette L Bruijstens; Katelijn M Blok; Joost Smolders; Beatrijs Ha Wokke; Rinze F Neuteboom

doi:10.1177/1352458520921367

Pediatric MS patients with a primary progressive-like disease may still have relevant inflammatory activity and may benefit from regular MS treatment

Arlette L Bruijstens, Katelijn M Blok, Joost Smolders, Beatrijs Ha Wokke, Rinze F Neuteboom

Netherlands Institute for Neuroscience (NIN)

Research output: Contribution to journal/periodical › Article › Scientific › peer-review

49 Downloads (Pure)

Original language	English
Pages (from-to)	1352458520921367
Journal	Multiple Sclerosis
DOIs	https://doi.org/10.1177/1352458520921367
Publication status	E-pub ahead of print - 2020

Access to Document

10.1177/1352458520921367

Bruijstens2020Final published version, 444 KB

Cite this

Bruijstens, A. L., Blok, K. M., Smolders, J., Wokke, B. H., & Neuteboom, R. F. (2020). Pediatric MS patients with a primary progressive-like disease may still have relevant inflammatory activity and may benefit from regular MS treatment. Multiple Sclerosis, 1352458520921367. https://doi.org/10.1177/1352458520921367

@article{54b11866aa8047389758573fcbf45bf6,

title = "Pediatric MS patients with a primary progressive-like disease may still have relevant inflammatory activity and may benefit from regular MS treatment",

author = "Bruijstens, {Arlette L} and Blok, {Katelijn M} and Joost Smolders and Wokke, {Beatrijs Ha} and Neuteboom, {Rinze F}",

year = "2020",

doi = "10.1177/1352458520921367",

language = "English",

pages = "1352458520921367",

journal = "Multiple Sclerosis",

issn = "1352-4585",

publisher = "SAGE Publications",

}

Pediatric MS patients with a primary progressive-like disease may still have relevant inflammatory activity and may benefit from regular MS treatment. / Bruijstens, Arlette L; Blok, Katelijn M; Smolders, Joost; Wokke, Beatrijs Ha; Neuteboom, Rinze F.

In: Multiple Sclerosis, 2020, p. 1352458520921367.

Research output: Contribution to journal/periodical › Article › Scientific › peer-review

TY - JOUR

T1 - Pediatric MS patients with a primary progressive-like disease may still have relevant inflammatory activity and may benefit from regular MS treatment

AU - Bruijstens, Arlette L

AU - Blok, Katelijn M

AU - Smolders, Joost

AU - Wokke, Beatrijs Ha

AU - Neuteboom, Rinze F

PY - 2020

Y1 - 2020

U2 - 10.1177/1352458520921367

DO - 10.1177/1352458520921367

M3 - Article

C2 - 32406801

SP - 1352458520921367

JO - Multiple Sclerosis

JF - Multiple Sclerosis

SN - 1352-4585

ER -